Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months Science 30. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Pharmacokinetics, pharmacodynamics, and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study. Science 27. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
100 Jahre Insuline Vergangenheit – Gegenwart – Zukunft / Insuline: Was können sie – worauf hoffen wir? Science 27. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Paradigmenwechsel in der Glukosekontrolle: Urin-, Blut-, interstitielle Glukosemessung. Science 25. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Kardiovaskuläre Sicherheit oraler Antidiabetika. Diabetes Form Science 25. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes. Science 25. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Single and Repeated Doses of EGb 761® do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects. Science 25. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
First-in-human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics. Science 24. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Diabetes Mellitus and the Heart. Science 24. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant. Science 24. Januar 2023 ShareTwitterFacebookXingLinkedin Read Article
